Predictive Enrollment Engineering™

Predictive Enrollment Engineering™ is a methodology that applies engineering principles, probabilistic modeling, and systems thinking to clinical trial patient enrollment. It is written for clinical research professionals — sponsors, contract research organizations, site networks, and principal investigators — as an educational and reference resource rather than a commercial offering. The premise is simple: enrollment should be forecastable, measurable, and engineered in the same way manufacturing throughput or supply chain performance is engineered, instead of being left to vendor anecdote and hope.

Why traditional enrollment fails

The industry conflates recruitment — generating interest — with enrollment, which is the conversion of an interested person into a consented, screened, and randomized study participant. Traditional site selection relies on claims about "robust databases" and on adding sites when a study falls behind. Neither addresses the underlying conversion problem: interest that is never contacted quickly, appointments that are never kept, and screening visits that never convert. Because no stage of that chain is instrumented, failures are discovered months late, when timelines and budgets have already been consumed.

Why enrollment must be engineered

Engineering enrollment means designing a system with defined inputs, measured stage-to-stage conversion, and predictable outputs. Every transition — interest to prescreen, prescreen to contact, contact to visit, screen to enroll — carries a probability that can be measured, benchmarked, and improved. Once those probabilities exist, enrollment ceases to be a guess: study duration, achievable patient counts, and expected cost per enrolled patient can be forecast in advance, with confidence intervals rather than single-point promises.

Core principles of Predictive Enrollment Engineering™

Enrollment as an engineering discipline — defined processes, quality controls, and continuous improvement applied with manufacturing-grade rigor.
Probability-based forecasting — disease prevalence, demographic modeling, and historical conversion rates converted into statistical confidence intervals instead of guesswork.
Funnel optimization — every patient touchpoint from initial awareness to informed consent is a measurable stage that can be diagnosed and improved.
Direct-to-site efficiency — removing intermediaries and delivering leads to sites in real time sharply reduces patient attrition.
Accountability through alignment — when commercial success is tied to enrolled patients, every stakeholder optimizes the same outcome.

Participant psychology and retention

Each funnel stage is designed around what it takes to attract, earn, solidify, and retain a prospective participant's trust. Trust accumulates: clarity at the first touchpoint raises response at the next, and the compounding effect reduces dropout after a participant has already agreed to enroll — the point at which attrition is most costly to a study.

Explore this site

The Framework — the full methodology reference: funnel modeling, conversion metrics, probability-based forecasting, participant psychology, and implementation guidance.
Articles & Insights — original analysis and synthesis on enrollment operations.
About the Author — Alen Hadzic, founder of Predictive Enrollment Engineering™ and CEO of Clinical Trial Scan™.
Contact — how to reach the editorial team.
Privacy Policy — what this site does and does not collect.
llms.txt — machine-readable site summary and guidance for AI agents.
sitemap.xml — full URL index.